
Hemu Bio
荷牧生物
Hemu Bio
Other
Hemu Biotechnology was jointly established by an advanced domestic technology development team and a strong management team. It is China's first innovative R&D company focused on next-generation mRNA vaccines for animals.
Latest round: Series A Extension (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.